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ABSTRACT
The carboxyl-terminal domain (CTD) of the largest subunit of eukaryotic RNA polymerase II (pol II) plays an important
role in promoting steps of pre-mRNA processing. To identify proteins in human cells that bind to the CTD and that
could mediate its functions in pre-mRNA processing, we used the mouse CTD expressed in bacterial cells in affinity
chromatography experiments. Two proteins present in HeLa cell extract, the splicing and transcription-associated
factors, PSF and p54nrb/NonO, bound specifically and could be purified to virtual homogeneity by chromatography on
immobilized CTD matrices. Both hypo- and hyperphosphorylated CTD matrices bound these proteins with similar
selectivity. PSF and p54nrb/NonO also copurified with a holoenzyme form of pol II containing hypophosphorylated
CTD and could be coimmunoprecipitated with antibodies specific for this and the hyperphosphorylated form of pol
II. That PSF and p54nrb/NonO promoted the binding of RNA to immobilized CTD matrices suggested these proteins can
interact with the CTD and RNA simultaneously. PSF and p54nrb/NonO may therefore provide a direct physical link
between the pol II CTD and pre-mRNA processing components, at both the initiation and elongation phases of
transcription.
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INTRODUCTION
Transcription and precursor (pre-)mRNA processing are
highly coordinated events in gene expression and can
influence one another+ The carboxyl-terminal domain
(CTD) of the largest subunit of RNA polymerase II (pol
II) has important roles in coupling transcription to dif-
ferent steps in the processing of pre-mRNA, including
formation of a 59-end cap, splicing, and 39-end forma-
tion (reviewed in Steinmetz, 1997; Hirose & Manley,
2000; Cramer et al+, 2001)+ The CTD consists of tan-
dem repeats of the heptapeptide consensus sequence
YSPTSPS, of which there are 26 or 27 in the largest
subunit of Saccharomyces cerevisiae RNA pol II (Alli-
son et al+, 1985; Nonet et al+, 1987) and 52 in the mam-
malian enzyme (Corden et al+, 1985)+ During initiation
of transcription, RNA pol II with a hypophosphorylated
CTD (pol IIa) is recruited to the promoter as part of a
large multiprotein holoenzyme complex (Lu et al+, 1991;
Kim et al+, 1994; Koleske & Young, 1994; Ossipow et al+,
1995; Pan et al+, 1997)+ The CTD is then hyperphos-
phorylated, primarily by the cyclin-dependent kinase
(Cdk9) subunit of the elongation factor P-TEFb, result-
ing in a more processive, elongating form of RNA pol II
(pol IIo) (reviewed in Dahmus, 1996; Conaway et al+,
2000)+ The CTD has been implicated in the response of
RNA pol II to sequence-specific DNA-binding transcrip-
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tional activator proteins (Allison & Ingles, 1989; Scafe
et al+, 1990; Gerber et al+, 1995) and requires the me-
diator complex, with which it interacts, for this activated
transcription (Kim et al+, 1994)+
In mammalian cells, truncation of the CTD prevents
the efficient capping, splicing, and 39 processing of na-
scent transcripts (McCracken et al+, 1997a, 1997b) and
reduces the accumulation of splicing factors at sites of
transcription in vivo (Misteli & Spector, 1999)+ Experi-
ments performed in vitro also argue for an important
role of the CTD in splicing and polyadenylation+ For
example, anti-CTD antibodies can inhibit pre-mRNA
splicing (Yuryev et al+, 1996) and both RNA pol IIo
(Hirose et al+, 1999) and the CTD itself can stimulate
splicing (Zeng & Berget, 2000)+ The 39-end processing
of nascent transcripts is also activated in vitro by the
addition of purified RNA pol II or the CTD (Hirose &
Manley, 1998)+ In an apparently reciprocal manner, splic-
ing factors bound to nascent RNA can stimulate elon-
gation of transcription, probably through interactions
mediated by the elongation factor Tat-SF1, which ap-
pears to interact with both splicing snRNPs and P-TEFb
(Fong & Zhou, 2001)+ Consistent with an important role
for the CTD in mediating the coupling of transcription
and pre-mRNA processing, splicing components (Mor-
tillaro et al+, 1996; Vincent et al+, 1996; Yuryev et al+,
1996; Kim et al+, 1997; Morris & Greenleaf, 2000), 59
capping enzymes (Yue et al+, 1997; McCracken et al+,
1997b; Ho et al+, 1998), and 39 processing factors (Mc-
Cracken et al+, 1997a; Barilla et al+, 2001) have all been
found to interact with the CTD+
Although a role for the CTD in promoting steps in
pre-mRNA processing has been established, it is not
known at which stage of the transcription cycle splicing
components are recruited to RNA pol II complexes, nor
which factors bound to the CTD coordinate transcrip-
tion and splicing+ Recent studies have provided evi-
dence that recognition of promoter sequences by the
transcriptional machinery can influence the ability of
specific SR (serine/arginine repeat) family splicing fac-
tors to promote alternative exon inclusion in reporter
transcripts (Cramer et al+, 1999)+ Moreover, SR family
proteins and other splicing factors have recently been
detected in purified holoenzyme complexes containing
RNA pol IIa (Robert et al+, 2001)+ However, the rela-
tionship between these observations and previous work
demonstrating a role for the CTD in pre-mRNA splicing
is not known+
To learn more about the functions of the CTD, we
have used affinity chromatography to identify proteins
that bind to the CTD in mammalian cells+ We demon-
strate that polypyrimidine tract binding protein- (PTB)
associated splicing factor (PSF; Patton et al+, 1993)
and p54nrb/NonO (Dong et al+, 1993; Yang et al+, 1993),
two proteins that share considerable amino acid se-
quence homology and that copurify in a complex (Zhang
et al+, 1993; Straub et al+, 1998; Zhang & Carmichael,
2001), bind specifically and can be purified to near
homogeneity from HeLa cell extracts by chromatogra-
phy on an immobilized CTD matrix+ Experiments sug-
gesting that PSF and p54nrb/NonO can bind the CTD
and RNA simultaneously, and the demonstration that
PSF and p54nrb/NonO are associated with both the
hypophosphorylated and hyperphosphorylated forms
of RNA polymerase II in HeLa cell extracts, indicate
that these two proteins could provide a direct physical
link between RNA polymerase and other pre-mRNA
processing components during the initiation and elon-
gation phases of transcription+
RESULTS
Interaction of PSF and p54nrb/NonO
with the pol II CTD
To identify human proteins that interact with the CTD of
the largest subunit of RNA polymerase II, we first ex-
pressed and purified a recombinant version of the mouse
CTD with an N-terminal polyhistidine tag+ This form of
recombinant CTD was abundantly expressed in Esch-
erichia coli cells in a soluble form and readily purified
by Ni21-chelate affinity chromatography+ A western blot
analysis (Fig+ 1A) showed that the recombinant CTD
polypeptide was bound by the monoclonal antibody
JEL352 (Moyle et al+, 1989), a reagent that preferen-
tially recognizes the nonphosphorylated form of the
CTD+ A series of affinity columns containing increasing
concentrations of covalently coupled CTD ligand were
loaded with HeLa whole-cell extract+ After extensive
washes with buffer containing 0+1 M NaCl, these
columns were eluted with high salt and the eluates
analyzed by SDS-PAGE and silver staining+As the con-
centration of immobilized CTD on the affinity columns
was increased, there was a corresponding increase
in the recovery of a number of proteins in the high
salt eluates+ Two of the more prominent proteins (seen
in Fig+ 1B as negatively staining broad bands) that
bound preferentially to the CTD had apparent molec-
ular masses of approximately 100 and 60 kDa; other
CTD-binding proteins had masses of 180, 80, 40, 36,
34, and 32 kDa+
To identify proteins present in HeLa cell extracts that
bound specifically to the CTD, the affinity chromatog-
raphy purification scheme was scaled up+ The input
HeLa cell extract, first precleared by passage over an
AffiGel-10 matrix containing no coupled protein, was
then sequentially bound to and eluted from two CTD
columns+ The two most abundant polypeptides seen in
Figure 1B, ;100 and ;60 kDa in size, were selectively
purified to near homogeneity+ After preparative-scale
SDS gel electrophoresis of the high salt eluate from the
second CTD column (Fig+ 1C), the bands correspond-
ing to these two proteins were subjected to proteolytic
digestion in situ with trypsin+ The resulting peptides
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were resolved by reverse phase HPLC and subjected
to N-terminal (Edman) amino acid sequence determi-
nation+ Peptides with the sequence YGEPGEVFINK
and ERETPPRFAQHGTFEYEYSQR from the 100-kDa
band and ALDR and EREQPPRFAQPGSFEYEYAMR
from the 60-kDa band were obtained+ A search of the
GenBank protein sequence database identified perfect
matches between the peptide sequences from the
;100-kDa protein and sequences within the human
RNA/DNA-binding protein PSF (Patton et al+, 1993)+
The peptides from the 60-kDa protein were identical to
sequences within the related mammalian RNA/DNA-
binding protein p54nrb/NonO+ These two proteins share
71% identity within a central 320-amino-acid region that
includes two tandem RNA recognition motifs (RRMs), a
helix-turn-helix (HTH) domain, and a domain that is
rich in charged amino acid residues (Dong et al+, 1993;
Patton et al+, 1993; Yang et al+, 1993)+
To verify that PSF and p54nrb/NonO are capable of
interacting with the CTD, we performed western blot
analyses of high salt elutes from CTD and control af-
finity columns loaded with HeLa cell extract, using poly-
clonal antibodies raised against either PSF (Fig+ 2A) or
p54nrb/NonO (data not shown)+ A single anti-PSF im-
munoreactive band with the same mobility as the form
of this polypeptide present in HeLa cell extract, and as
a recombinant PSF protein whose expression was in-
duced in E. coli cells, was present in the high-salt elu-
ate of the CTD column but not a control column lacking
bound CTD+ As both PSF and p54nrb/NonO have RNA-
binding motifs (Dong et al+, 1993; Patton et al+, 1993;
Yang et al+, 1993) and may be capable of interacting
with either RNA or DNA (Basu et al+, 1997; Yang et al+,
1997), the interaction of these two proteins with the
CTD might, in theory, be mediated through a nucleic
acid intermediate+ This possibility, however, seems un-
likely, as extensive treatment of the input HeLa cell
extract with either ribonuclease A or micrococcal nu-
clease did not impair the binding of PSF and p54nrb/
NonO to a CTD affinity column (data not shown; see
also Fig+ 2B)+ Furthermore, the eluates from our CTD
columns did not contain significant amounts of nucleic
acid as detected by labeling with T4 polynucleotide
kinase (data not shown)+
The apparent 1:1 stoichiometry (Fig+ 1C) of the PSF
and p54nrb/NonO polypeptides in the CTD affinity col-
umn eluates suggested that they may form a stable
heterodimeric complex+ Indeed, such a 1:1 heterodi-
meric mixture of these same two proteins, first purified
from HeLa cells as an activity binding to the upstream
region of the human proliferation-associated antigen
p120 gene (Zhang et al+, 1993), has also been found in
human A431 cell extracts associated with a third poly-
peptide, topoisomerase I (Straub et al+, 1998)+ In an-
FIGURE 1. Identification of PSF and p54nrb/NonO as pol II CTD-binding proteins+ A: His-tagged recombinant mouse CTD
was expressed in E. coli, purified by Ni21-chelate chromatography, and analyzed after SDS-PAGE by Coomassie blue
staining (lane 1) and western blotting (lane 2) with the anti-CTD monoclonal antibody JEL352 (Moyle et al+, 1989)+
B: Silver-stained SDS-gel of the high salt eluates of a series of 20-mL affinity columns containing the indicated concentration
of immobilized mouse CTD+ The columns were loaded with 300 mL HeLa whole-cell extract+ Closed arrowheads indicate the
positions of two overloaded and negatively staining polypeptides binding specifically to the CTD matrix; open arrowheads,
other CTD-binding proteins+ C: Coomassie blue-stained SDS gel showing the preparation of CTD-binding proteins sub-
jected to microsequence analysis+ Protein bands subsequently identified as PSF and p54nrb/NonO are indicated+
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other study, PSF and p54nrb/NonO were found to be
present in a complex with the inner nuclear matrix pro-
tein, matrin 3, bound specifically to inosine-containing
RNAs (Zhang & Carmichael, 2001)+ Neither the 91-kDa
topoisomerase I nor the 125-kDa matrin 3 polypeptide
were present with PSF and p54nrb/NonO in the eluate
of our CTD columns (Fig+ 1C, see also Fig+ 2B)+ The
absence of matrin 3 in our eluates is consistent with the
observation that it readily dissociates from PSF and
p54nrb/NonO during complex isolation (Zhang & Car-
michael, 2001)+ Moreover, p54nrb/NonO and topoisom-
erase I may have copurified because of their abilities to
each bind the nickel–agarose affinity matrix (Straub
et al+, 1998; Zhang & Carmichael, 2001)+ The obser-
vation that the mixture of PSF and p54nrb/NonO binds
efficiently to a CTD affinity column upon rechromatog-
raphy, and essentially no other polypeptides are de-
tected in the eluates from this second CTD column
(see Fig+ 1C), indicates that the interaction between the
CTD and one or both of these components is direct and
is not mediated by any other protein in HeLa cell extract+
Our attempts to delineate a CTD-binding domain
within either of these proteins were unsuccessful+ Un-
like the proteins purified from human cell extracts, nei-
ther recombinant PSF nor recombinant p54nrb/NonO or
a mixture of these two proteins expressed in E. coli
cells bound efficiently to the CTD affinity matrix (data
not shown)+ These recombinant proteins may therefore
require one or more posttranslational modifications to
bind the CTD efficiently+ Consistent with this possibility,
cellular forms of both PSF and p54nrb/NonO are known
to contain phosphorylated tyrosine residues (Otto et al+,
2001)+ Such modifications could influence the ability of
these proteins to interact with other cellular components+
PSF and p54nrb/NonO bind
the phosphorylated and
nonphosphorylated CTD
Our initial identification of PSF and p54nrb/NonO as
CTD binding proteins by affinity chromatography em-
ployed a nonphosphorylated CTD ligand+ It was impor-
tant, therefore, to determine the effect of phosphorylation
of the CTD on this interaction because the elongating
form of RNA polymerase II is multiply phosphorylated
on the Ser-2 and Ser-5 positions within the YSPTSPS
heptad repeat and this phosphorylation is important
for the association of some of the factors that function
in pre-mRNA processing (Mortillaro et al+, 1996; Yue
et al+, 1997; McCracken et al+, 1997b; Ho et al+, 1998;
FIGURE 2. PSF and p54nrb/NonO bind the RNA pol II CTD+ A: Western blot of an SDS gel probed with polyclonal anti-PSF
serum; HeLa cell extract (lane 1) was loaded on control and CTD columns; high salt eluates from the control and CTD affinity
column (lanes 2 and 3); cell extracts from E. coli cells uninduced and induced to express recombinant human PSF (lanes 4
and 5)+ B: Silver-stained SDS-gel analysis of the high salt eluates from affinity columns containing ligands bound at 4
mg/mL; bound GST (lane 2) GST-CTD (lane 3), or the phosphorylated GST-CTD derivative (lanes 4)+ The identity of the
indicated CTD-binding proteins was determined after proteolysis and MALDI-TOF mass spectrometry+ Lane 1 is an aliquot
of the HeLa cell extract prefractionated by Ni21-chelate chromatography (Straub et al+, 1998) that was loaded on each
column+ The additional polypeptides, indicated by asterisks, were identified by MALDI-TOF mass spectrometry as GST-
CTD-derived polypeptides that leached from the columns+
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Patturajan et al+, 1998b; Komarnitsky et al+, 2000;
Schroeder et al+, 2000; Pei et al+, 2001)+ For these
experiments, we employed the immobilized GST-
CTD ligands described earlier by McCracken et al+
(1997a), including a GST–CTD derivative that was
enzymatically phosphorylated by preincubation in nu-
clear extract+ HeLa nuclear extract was pretreated with
DNase and RNase, prefractionated by Ni21-chelate
chromatography to enrich for PSF and p54nrb/NonO
(Straub et al+, 1998), and then chromatographed on
affinity columns containing GST, the GST-CTD or the
phosphorylated GST-CTD derivative (Fig+ 2B)+ The shift
in mobility of the phosphorylated GST-CTD ligand (see
Fig+ 2B) indicated that it was phosphorylated to a
degree similar to that of pol IIo+ The high salt eluates
from these columns were analyzed by SDS-PAGE and
the major proteins bound to these CTD matrices were
then identified by MALDI-TOF mass spectrometry+ As
shown in Figure 2B, of all the proteins present in the
partially fractionated cell extract that was loaded on
the columns, only PSF and p54nrb/NonO bound effi-
ciently to both the phosphorylated and nonphosphor-
ylated GST-CTD ligands+ Although the binding of the
phosphorylated CTD could reflect an interaction with
remaining nonphosphorylated heptad repeats, the re-
sults demonstrate that hyperphosphorylation of the
CTD does not reduce binding of these two proteins+
These chromatography experiments again demon-
strate the remarkable selectivity of the CTD in bind-
ing a very limited number of proteins+ Essentially only
PSF and p54nrb/NonO bound the CTD+
PSF and p54nrb/NonO associate with both
the RNA pol IIa holoenzyme and
phosphorylated RNA pol IIo
As potential components of pre-mRNA processing com-
plexes, PSF and p54nrb/NonO might have been ex-
pected to preferentially associate, like pre-mRNA
capping enzymes (McCracken et al+, 1997b; Yue et al+,
1997; Ho et al+, 1998), with the phosphorylated CTD
present on elongating RNA pol IIo+ The affinity chro-
matography experiment shown in Figure 2B, however,
suggests that these two proteins might bind equally
well to both nonphosphorylated and phosphorylated
versions of the CTD heptad repeats and thus be asso-
ciated with both pol IIa and pol IIo in mammalian cells+
To explore this possibility, we first used the procedure
described by Pan et al+ (1997) of affinity chromatogra-
phy on an immobilized human TFIIS matrix to isolate
the hypophosphorylated RNA pol IIa-containing holo-
enzyme complex+ We used western blot analyses to
ascertain the relative abundance of PSF and p54nrb/
NonO in the isolated pol IIa holoenzyme+ As shown in
Figure 3A, these immunoblots indicated that both PSF
and p54nrb/NonO are present, along with the expected
general initiation factors such as TFIIB and TFIIE, in
the pol IIa holoenzyme complex+ By comparison to re-
combinant standards, we were able to estimate the
relative content of these proteins in the complex+ Per-
haps not surprisingly, given the presence of 52 heptad
repeats within human pol II CTD, both PSF and p54nrb/
NonO were present in the pol II holoenzyme at stoichi-
ometries considerably greater than 1:1+ In contrast to
the 56-kDa subunit of TFIIE and the TFIIB polypeptide,
which were present in this preparation of holoenzyme
in near equimolar amounts (0+8:1 and 1+3:1, respec-
tively, relative to the pol II largest subunit), PSF and
p54nrb/NonO were present in this holoenzyme prepa-
ration in stoichiometries of 3+5:1 and 23:1, respectively+
That we did not find equivalent amounts of PSF and
p54nrb/NonO in this holoenzyme preparation may re-
flect the different stabilities of the interactions of
these two proteins with the CTD during isolation of the
holoenzyme+
We also used coimmunoprecipitation to ask whether
PSF and p54nrb/NonO associate with the two differ-
ent forms of RNA polymerase II+ Consistent with the
detection of both PSF and p54nrb/NonO in purified
holoenzyme containing pol IIa, antibodies to p54nrb/
NonO (Fig+ 3B) and PSF (Fig+ 3C) detected these
proteins in coimmunoprecipitates prepared from HeLa
and Cos7 nuclear extracts using the monoclonal anti-
body 8WG16, which preferentially recognizes the hypo-
phosphorylated CTD in RNA pol IIa+ To verify whether
PSF also associates with the hyperphosphorylated pol
IIo, we used mAb B3, which has been shown previ-
ously to specifically recognize only pol IIo, and not
pol IIa, through binding to specific CTD phosphoepi-
topes (Mortillaro et al+, 1996; Patturajan et al+, 1998a)+
Pol IIo immunoprecipitates were collected from HeLa
cell nuclear extract with mAb B3 and then immuno-
blotted with an antiserum specific for PSF+ The immu-
noblot shown in Figure 3D indicates that PSF is
associated with pol IIo in HeLa nuclear extract+ This
coimmunoprecipitation appears specific, as PSF is not
detected in a control immunoprecipitate prepared with
an antibody (mAb-B1C8) to the splicing coactivator
SRm160+ Taken together with the demonstration that
PSF and p54nrb/NonO bind to both the hypo- and
hyperphosphorylated forms of the CTD and associ-
ate with the holoenzyme, our results indicate that these
proteins interact with both the pol IIa and pol IIo forms
of RNA polymerase+
PSF and p54nrb/NonO can facilitate the
association of RNA with the CTD
To investigate whether PSF or p54nrb/NonO has the
potential to couple the CTD to pre-mRNA processing
components, we asked whether these two proteins are
able to facilitate the association of RNA with an immo-
bilized CTD matrix+ GST-CTD and GST columns, either
preincubated or not with PSF and p54nrb/NonO pro-
1106 A. Emili et al.
 Cold Spring Harbor Laboratory Press on January 8, 2014 - Published by rnajournal.cshlp.orgDownloaded from 
teins, were assayed for their ability to retain a radio-
labeled RNA transcript (see Materials and Methods for
details)+ With the GST-CTD column preincubated with
PSF and p54nrb/NonO, 68% of the RNA was retained
on the column+ Only 37% of the RNA was retained on
the GST-CTD column not preincubated with PSF and
p54nrb/NonO (Fig+ 4)+ This increase in retention of RNA
was specific, for when PSF and p54nrb/NonO were pre-
incubated with a control GST column matrix prior to
RNA addition, the level of RNA bound was similar to
the background level retained on a column containing
only GST alone (;10%; Fig+ 4)+ The ability of the GST-
CTD matrix to retain a fraction of RNA in the absence
of PSF and p54nrb/NonO proteins suggests that the
CTD itself may have RNA-binding activity, although we
cannot exclude that low levels of copurifying proteins in
the GST-CTD preparations might account for at least
some of this binding activity+ Nevertheless, the results
demonstrate that a highly purified preparation of PSF
and p54nrb/NonO proteins can facilitate the association
of RNA with the CTD+ Taken together with the results
described above, our data are consistent with a role for
these proteins in linking pre-mRNA processing events
at different stages of transcription+
FIGURE 4. PSF and p54nrb/NonO increase RNA binding to a GST-
CTD matrix+ PSF and p54nrb/NonO (PSF/p54) were preincubated
with immobilized GST-CTD or GST alone+ Each column was then
incubated with 32P-labeled RNA and washed+ The amount of RNA
retained by each column was determined+ RNA retained by control
GST and GST-CTD columns not incubated with PSF and p54nrb/
NonO was also determined+
FIGURE 3. PSF and p54nrb/NonO are associated with both RNA pol IIa and pol IIo+ A: Aliquots of a preparation of a
TFIIS-affinity purified RNA pol II holoenzyme complex, and of preparations of purified recombinant TFIIE-56, TFIIB, PSF, and
p54nrb/NonO, were fractionated by SDS-PAGE, transferred to nitrocellulose, and western blotted with the appropriate
antibodies+ B: HeLa nuclear extract was first immunoprecipitated with a control monoclonal antibody (anti-Foxp1; lane 1) or
with the 8WG16 monoclonal antibody (lane 2), and the immunoprecipitates after SDS-PAGE fractionation were western
blotted with anti-p54nrb/NonO polyclonal antibodies+ C: Extracts from Cos7 cells transiently expressing human PSF were
similarly immunoprecipitated with control (anti-Foxp1; lane 1) or 8WG16 antibodies (lane 2) and the fractionated immuno-
precipitates were western blotted with an anti-PSF polyclonal antibody+ D: HeLa nuclear extract was immunoprecipitated
with either the phosphorylated CTD-specific monoclonal antibody B3 or a control antibody B1C8+ An aliquot (5%) of the
supernatants and one-half of the immunoprecipitated proteins were separated by SDS-PAGE, transferred to nitrocellulose
and western blotted with anti-PSF antibodies+ Immunoblotted proteins were visualized with an ECL system (Amersham
Pharmacia)+
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DISCUSSION
Previous work has implicated PSF and p54nrb/NonO at
a number of steps in RNA processing+ Both proteins
preferentially associate with RNA sequences in pre-
mRNA+ PSF was first identified as a factor that asso-
ciates with PTB, and was shown to be required at an
early step in spliceosome formation (Patton et al+, 1993)+
Subsequent data suggested that PSF may also play an
important role in catalytic step II of splicing (Gozani
et al+, 1994)+ PSF was also identified as a component
of a snRNP-free complex (SF-A) that contains the U1
snRNP-specific A protein and is implicated in the 39-
end cleavage of transcripts (Lutz et al+, 1998)+ More
recently, a complex consisting of PSF, p54nrb/NonO,
and matrin 3, an integral nuclear matrix protein that
contains two RRMs as well as putative zinc fingers and
other motifs, was shown to function in the nuclear re-
tention of edited transcripts containing inosine residues
(Zhang & Carmichael, 2001)+
In addition to these roles in RNA processing, PSF
and p54nrb/NonO have also been implicated in tran-
scriptional control+ Both proteins have been shown to
bind different DNA-binding nuclear hormone receptors
and may modulate transcriptional activity (Basu et al+,
1997; Yang et al+, 1997; Urban et al+, 2000; Mathur
et al+, 2001)+ Moreover, both proteins concentrate within
speckle or speckle-associated domains in the nucleus
that are enriched in splicing-related proteins as well as
RNA pol IIo (Patton et al+, 1993; Mortillaro et al+, 1996;
Kim et al+, 1997; Dye & Patton, 2001; Fox et al+, 2002)+
Our results demonstrating that PSF and p54nrb/NonO
bind to the CTD are consistent with these two proteins
having roles in transcription as well as RNA processing
and suggest that they may participate in the coupling of
these processes in gene expression+ Although these
proteins could directly function in pre-mRNA process-
ing when bound to the CTD, they might have a more
indirect role, such as folding of the CTD into a form
that can participate in pre-mRNA processing+ Such a
chaperone-like function for PSF and p54nrb/NonO would
be consistent with their identification in several differ-
ent complexes+ Both proteins could function in an anal-
ogous manner to the RRM-containing protein REF/Aly/
BEF, a chaperone facilitating the DNA-binding activity
of basic region-leucine zipper (bZIP) proteins (Virba-
sius et al+, 1999), and in other contexts a factor partici-
pating in the coupling of splicing and mRNA export
(Zhou et al+, 2000; Rodrigues et al+, 2001)+
The identification of PSF and p54nrb/NonO, in asso-
ciation with both pol IIa and pol IIo forms of RNA poly-
merase II, suggests that they could provide a link
between RNA processing events at both the pol IIa-
dependent steps of transcription initiation and the pol
IIo-dependent elongation phases of transcription+ Such
a role might be effected directly by these proteins, or
else indirectly through the interaction with one or more
additional factors such as PTB, which binds to PSF
and has multiple roles in the regulation of alternative
splicing (Patton et al+, 1993; reviewed in Wagner &
Garcia-Blanco, 2001)+ Interestingly, several splicing fac-
tors, including SR family proteins, snRNP components,
and the 65-kDa subunit of snRNP auxiliary factor (U2AF-
65), were recently detected by western blot analysis in
pol IIa holoenzyme complexes (Robert et al+, 2001)+
Although it was not determined whether these splicing
factors were binding to the CTD directly, it is possible
that they, like PSF and p54nrb/NonO, might participate
in linking transcription to pre-mRNA processing prior to
transcription initiation+ Because the in vitro experi-
ments of Hirose and Manley showed that purified pol
IIo can promote presplicing complex formation in S100
extracts of HeLa cells that lack pol II (Hirose et al+,
1999), a process that is also dependent on PSF (Pat-
ton et al+, 1993), it is possible that pol IIo might be
stimulating splicing complex formation through an inter-
action between PSF and its CTD+ Similarly, as a com-
ponent of the SF-A complex (Lutz et al+, 1998), PSF,
through binding to the CTD, may also link transcription
to SF-A-dependent processing steps such as 39-end
cleavage+ In conclusion, our identification of PSF and
p54nrb/NonO as CTD-binding proteins suggests that
these proteins could provide a mechanism by which
different steps in pre-mRNA synthesis and processing
are temporally and spatially coupled within the mam-
malian cell nucleus+
MATERIALS AND METHODS
Recombinant proteins
The mouse RNA pol II CTD was expressed in E. coli cells as
an N-terminally poly(10)histidine-tagged protein after sub-
cloning the corresponding cDNA encoding the entire CTD
from the plasmid pGCTD (Peterson et al+, 1992; a gift of W+
Dynan) into pET19b (Novagen)+ The mouse CTD was also
expressed in E. coli cells as a GST-CTD derivative as de-
scribed by McCracken et al+ (1997a), using a plasmid that
was a gift of D+ Bentley+ The E. coli expression plasmid for
poly(10)histidine tagged PSF (Patton et al+, 1993) and cDNA
encoding p54nrb/NonO (Dong et al+, 1993) were obtained
from J+ Patton and A+ Krainer, respectively+ The three corre-
sponding recombinant proteins were expressed as his-tagged
products in BL21(DE3) cells and purified by Ni21-chelate
chromatography (Emili & Ingles, 1995)+
Affinity chromatography
HeLa whole-cell extracts (10 mg protein/mL) were prepared
and chromatographed on Affigel 10 (BioRad) matrices as
previously described (Sopta et al+, 1985), using affinity col-
umn buffer (ACB; 20 mM HEPES-NaOH, pH 7+9, 20% glyc-
erol, 0+1 mM EDTA, 1 mM DTT, and either 0+1 M or 1+0 M
NaCl)+
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Protein purification and identification
Forty milliliters of HeLa cell extract were first chromato-
graphed on a 2+0-mL column of Affigel containing no bound
protein, then applied to a 1+0-mL column containing 2+0 mg/mL
of immobilized-tagged CTD+ After washing with 10 vol+ of
ACB containing 0+1 M NaCl, bound proteins were eluted by
ACB containing 1+0 M NaCl, dialyzed and rechromatographed
on a second CTD column+ Peak fractions from the high salt
eluate of this column were precipitated by addition of one-fifth
of a volume of 0+15% deoxycholate and 70% TCA, separated
by SDS-PAGE and stained with ultrapure Coomassie Brilliant
Blue G-250 (Sigma) in 5% (v/v) acetic acid and 10% (v/v)
methanol+ The stained bands were excised and digested in
situ with trypsin+ Resulting peptides were fractionated by re-
verse phase HPLC and N-terminal sequences determined as
described (Wang et al+, 1996)+ Chromatography on GST-CTD
matrices was performed as described by McCracken et al+
(1997a)+ The proteins present in eluates from the GST-CTD
columns (Fig+ 2B) were digested in situ with trypsin and an-
alyzed by MALDI-TOF mass spectroscopy+ The RNA poly-
merase II holoenzyme complex was prepared from HeLa cell
extracts by chromatography on a matrix of Affigel-10-coupled
TFIIS as described by Pan et al+ (1997)+ For western blots of
PSF and p54nrb/NonO, immune serum was provided by J+
Patton and A+ Krainer, respectively+
Immunoprecipitation
Nuclear extract was prepared (Dignam et al+, 1983) in 10 mM
Tris, pH 7+6, 150 mM KCl, 0+1% NP40, 0+05% NaN3, 2+5 mM
MgCl2, 5 mM KF, and 5 mM b-glycerophosphate from HeLa
or Cos7 cells transiently expressing His-tagged PSF from the
plasmid pCR3+1His-PSF+ Immunoprecipitates were collected
on protein A-Sepharose beads prebound with the mono-
clonal antibodies B1C8 (specific for the SRm160 splicing co-
activator subunit; Blencowe et al+, 1998); B3 (specific for pol
IIo; Mortillaro et al+, 1996), or 8WG16 (specific for pol IIa;
Thompson et al+, 1990)+ The immunoprecipitates were sep-
arated by SDS-PAGE and western blotted with anti-PSF anti-
serum or anti-p54nrb/NonO antiserum+
RNA binding assays
Fifty microliters of glutathione Sepharose beads, precoupled
with GST-CTD (2+5 mg/mL) or GST (8 mg/mL), were equili-
brated with IP100 (10 mM Tris, pH 7+6, 0+1% Nonidet P40,
2+5 mM MgCl2, 5 mM KF, 5 mM b-glycerophosphate, 100 mM
KCl) in micro Bio-Spin chromatography columns (BioRad)+
Approximately 200 ng each of p54nrb/NonO and PSF (puri-
fied by GST-CTD affinity chromatography to near homogene-
ity; see Fig+ 2) was applied to each column in 300 mL of
IP100+ PSF and p54nrb/NonO were incubated on ice with the
column matrices for 75 min with occasional mixing+ Matching
control columns were prepared with GST-CTD and GST but
without PSF and p54nrb/NonO+ Columns were drained by
gravity and were washed with 3 aliquots of 100 mL IP50
(50 mM KCl)+ A 320-nt 32P-RNA transcript, corresponding to
the antisense strand from the middle of exon 4 to the 39 end
of the AAUAAA cleavage polyadenylation sequence of a re-
porter pre-mRNA derived from the Drosophila doublesex gene
(McCracken et al+, 2002), was diluted 1/100 in IP50+ We ap-
plied 100 mL to each column matrix and incubated it for 10 min
at room temperature with frequent gentle mixing prior to col-
lecting fractions+ The flow-through and wash fractions were
collected by gravity flow+ Columns were washed with 2 ali-
quots of IP50, 100 mL each+ Flow-through, wash fractions,
and the column matrices were assayed in a liquid scintillation
counter by Cherenkov counting+ “Percent counts retained” by
each column was calculated as: column counts/(flow-through
counts 1 wash counts 1 column counts) 3 100+
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